Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
A look at 2009 to 2014 data found that those in care for HIV saw a considerable fall in treatment deferrals.
This is according to the large randomized controlled START trial.
“I keep thinking, this is sub-Saharan Africa happening all over again.”
Living with chronic pain not only drags down quality of life, but it is also linked to poorer HIV-related health outcomes.
Highlights from HIV and hepatitis C research presented at the 2018 Conference on Retroviruses and Opportunistic Infections (CROI) in Boston
The average time between diagnosis and treatment start narrowed to just six days by 2016.
With a grant to follow their large study population through 2021, researchers hope to gain vital new insights about HIV infection.
This is according to an analysis of 35,000 people with high CD4 counts diagnosed with HIV in China.
Researchers discovered that higher levels of such cells were tied not only to infection risk but also HIV disease progression.
Since launching its “Getting to Zero” campaign in 2010, the city has seen a rapid decline in new diagnoses among other improvements.
But the median CD4 count at treatment start is below 350, which means work is needed to catch up to World Health Organization guidelines.
The country is urged to offer treatment to everyone who has HIV regardless of CD4 count; most cases are among young men.
He started HIV treatment immediately, and after sensitive tests showed near-complete loss of virus, he stopped after 34 months.
Although more research on antiretroviral linked bone loss is needed, the overall health benefits of early treatment outweigh such a risk.
Numerous low- and middle-income nations have taken great strides in getting their HIV populations on antiretrovirals more promptly.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.